Skip to search formSkip to main contentSkip to account menu

SN-307

Known as: SN 307, SN307 
National Institutes of Health

Related topics

Related topics

5 relations
GR38032FOndansetron 2 MG/ML Injectable SolutionZofran

Broader (2)

OndansetronOndansetron Hydrochloride

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1992
1992
[Evaluation of SN-307 (ondansetron), given intravenously in the treatment of nausea and vomiting caused by anticancer drugs including cisplatin--a placebo-controlled, double-blind comparative study].
Clinical usefulness of ondansetron as an antiemetic for the treatment of nausea and vomiting induced by anticancer drugs… 
1992
1992
[Examination of inhibitory effect, safety and usefulness of SN-307 (ondansetron) administered orally once daily for 3-5 consecutive days on nausea and emesis associated with non-platinum anti-cancer…
We examined the anti-emetic effect, safety and usefulness of ondansetron hydrochloride, a selective 5-HT3 receptor antagonist… 
1992
1992
[Evaluation of SN-307 (ondansetron), given intravenously for the treatment of nausea and vomiting caused by anticancer drugs including cisplatin-open study].
The anti-emetic effect, safety and clinical usefulness of ondansetron for the treatment of nausea and vomiting caused by… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)